Cencora appoints Robert Sanchez to its board. Cencora stock trades at EUR 281.10
Published on 10/06/2026 at 12:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cencora (ISIN US03073E1055) was trading at EUR 281.10 at Lang & Schwarz on October 6, 2026 at 12:00 p.m. CEST, up 0.18 percent versus the prior close of EUR 280.60. StockTitan reports that Cencora appointed Robert E. Sanchez as an independent director effective October 1, 2026, increasing the board from 10 to 11 members after the September 25, 2026 filing.
Third-quarter growth supports guidance
In fiscal third quarter 2026, revenue reached USD 84.75 billion, up 5.10 percent from the prior-year quarter, while GAAP diluted earnings per share rose to USD 3.94 from USD 3.52. Those figures are reported in the StockTitan summary of Cencora's August 5, 2026 filing.
Adjusted diluted earnings per share increased to USD 4.48 from USD 4.00 in the same fiscal quarter. Yahoo Finance records management's adjusted fiscal 2026 earnings-per-share outlook at USD 17.75-17.95, raised from USD 17.70-17.90.
Specialty operations shape the next step
The operating mix explains why the updated outlook matters. In fiscal third quarter 2026, U.S. Healthcare Solutions revenue was USD 74.9 billion, up 5.00 percent year over year, while segment operating income increased 16.00 percent to USD 966.0 million, according to Yahoo Finance.
The company also faces a clear operating counterweight: the same call said manufacturer list-price reductions created a USD 2.4 billion headwind to revenue growth in the quarter. That contrast leaves specialty utilization, OneOncology execution and margin conversion as the key variables behind the raised earnings outlook.
Next results date is November 4
Business Wire says Cencora plans to release fiscal fourth-quarter 2026 results on November 4, 2026, before trading opens on the New York Stock Exchange. As of October 5, 2026, Cencora's market capitalization was USD 61.3 billion, with a 52-week NYSE range of USD 244.82 to USD 377.54.
The further course of trading is shown by the continuously updated real-time quote of Cencora stock.
Cencora stock facts
- Company: Cencora, Inc.
- ISIN: US03073E1055
- Ticker: COR
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 6, 2026, 12:00 p.m. CEST): EUR 281.10
- Change versus prior close: plus 0.18 percent
- Prior close Lang & Schwarz (October 5, 2026): EUR 280.60
- Market capitalization: USD 61.3 billion (as of October 5, 2026)
- 52-week range: USD 244.82-377.54 (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical Distribution
- Next earnings date: November 4, 2026
